Criteo vs Omnicom
CRTO and OMC side by side, both in business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CRTO and OMC compare
Omnicom is the larger company, worth 31 times as much as Criteo ($22.3B against $718M).
Omnicom grew revenue faster over the last twelve months (40.6% versus 0.60% for Criteo).
Criteo keeps more of each dollar of sales as profit, with a net margin of 7.4% compared with 1.7% at Omnicom.
Omnicom pays a dividend yielding 3.9%; Criteo does not pay one.
Criteo scores higher on the StockData Score (19 against 8 for Omnicom), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CRTO | OMC |
|---|---|---|
| Size and price | ||
| Market cap | $718M | $22.3B |
| Share price | $14.65 | $81.26 |
| Change, 1 year | −33.9% | 8.0% |
| Change, 5 years | −64.0% | 18.1% |
| Beta (5Y) | 0.79 | 0.76 |
| Employees | 1,181 | 120K |
| StockData Score | ||
| Total score | 19 (better) | 8 |
| Valuation score | 6 (better) | 0 |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 2 |
| Health score | 5 (better) | 2 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | 5.5× | – |
| P/S | 0.4× (better) | 1.0× |
| P/B | 0.6× (better) | 2.3× |
| EV/EBITDA | 2.3× (better) | 18.3× |
| P/FCF | 3.4× (better) | 9.3× |
| PEG | 0.03 | – |
| FCF yield | 29.0% (better) | 10.7% |
| Fair value | $53.15 | $66.01 |
| Margin of safety | 72.4% (better) | −23.1% |
| Growth | ||
| Revenue growth (TTM) | 0.60% | 40.6% (better) |
| Revenue growth, 5Y average | −1.3% | 5.6% (better) |
| Net income growth (TTM) | 29.6% (better) | −71.7% |
| EPS growth (TTM) | 38.9% | – |
| EPS growth, 5Y average | 17.9% | – |
| Profitability | ||
| Gross margin | 54.0% (better) | 11.2% |
| Operating margin | 10.4% (better) | 5.0% |
| Net margin | 7.4% (better) | 1.7% |
| FCF margin | 10.7% (better) | 10.7% |
| Return on equity | 13.0% (better) | 5.5% |
| Return on invested capital | 17.4% (better) | 5.6% |
| Financial health | ||
| Debt / equity | 0.00 | 1.04 (better) |
| Net debt / EBITDA | – | 4.13 |
| Interest coverage | 82.4× (better) | 2.9× |
| Current ratio | 1.29 (better) | 0.92 |
| Altman Z-score | 2.35 (better) | 1.13 |
| Piotroski F-score | 9 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | – | 3.9% |
| Payout ratio | – | 193% |
| Years of dividend growth | – | 1 |
| Dividend growth, 5Y average | – | 2.2% |
| Buyback yield | 21.2% (better) | 15.6% |
| Shareholder yield | 21.2% (better) | 19.5% |
| Ownership | ||
| Held by institutions | 83.9% | 109% |
| Held by insiders | 4.0% | 0.98% |
| Insider net buying, 12 months | −$1.5M | −$238K (better) |
| Short interest, % of float | 2.4% | 8.9% |
Go deeper
- CRTO stock overview
- CRTO income statement
- CRTO valuation and score
- OMC stock overview
- OMC income statement
- OMC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.